Profil
Molly Cameron is currently the Director of Corporate Communications at Marinus Pharmaceuticals, Inc. She previously worked as the Manager of Media & Corporate Communications at Orchard Therapeutics Plc.
Aktive Positionen von Molly Cameron
| Unternehmen | Position | Beginn |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Public Communications Contact | - |
Ehemalige bekannte Positionen von Molly Cameron
| Unternehmen | Position | Ende |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Public Communications Contact | 01.04.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |